Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol |
Is a |
Neomycin-containing product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol |
Is a |
Hydrocortisone-containing product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol |
Is a |
Compound neomycin preparations |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol |
Is a |
Topical neomycin |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol |
Is a |
Product containing hydrocortisone in otic dose form (medicinal product form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Topical neomycin |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Adrenal hormone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol |
Is a |
Product containing hydrocortisone and neomycin sulfate and polymyxin B sulfate |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Neomycin sulphate |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
anti-infectieux cutané |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hydrocortisone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Polymyxin B sulfate (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Corticosterone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Adrenal hormone agent |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bactericide |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Local anti-infective |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol |
Has manufactured dose form |
Otic dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol |
Is a |
Product containing polymyxin B in otic dose form (medicinal product form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol |
Is a |
Product containing neomycin in otic dose form (medicinal product form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|